Crysvita

Crysvita - Psychology, Special Needs, Health - Posted: 17th Apr, 2018 - 11:54pm

Text RPG Play Text RPG ?
 

Posts: 1 - Views: 140
Drug for x-linked hypophosphatemia (XLH)
Post Date: 17th Apr, 2018 - 11:54pm / Post ID: #

NOTE: News [?]

Crysvita

The U.S. Food and Drug Administration today approved Crysvita (Burosumab), the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH), a rare, inherited form of rickets. XLH causes low levels of phosphorus in the blood. It leads to impaired bone growth and development in children and adolescents and problems with bone mineralization throughout a patient’s life. Source 3n.

Sponsored Links:


Comment Add Comment As A Guest
Important Guest, please be considerate by using the appropriate tags as well as checking your grammar before submitting or it will be deleted. See: Constructive Posting Policy.

# Characters:
0
# Words:
0
# Sentences:
0
# Paragraphs:
0
Reading Time:
0
Optional:
Search

Tip TIP: Press above button ONCE only. If you come back here via the [Back] button on your browser then you will need to click [More Options] button (below) first in order to re-enable your ability to Post.

 
> TOPIC: Crysvita
 



International Discussions Coded by: BGID®
ALL RIGHTS RESERVED Copyright © 1999-2024
Disclaimer Privacy Report Errors Credits
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in our Cookies used here: Privacy / Disclaimer,